Interobserver variability in interim PET assessment in Hodgkin lymphoma-reasons and solutions.

Interobserver variability in interim PET assessment in Hodgkin lymphoma-reasons and solutions.

<h4>Introduction</h4>Interim PET (iPET) assessment is important for response adaptation in Hodgkin lymphoma (HL). The current standard for iPET assessment is the Deauville score (DS). The aim of our study was to evaluate the causes of interobserver variability in assigning the DS for iPE...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Thomas W Georgi, Lars Kurch, Dirk Hasenclever, Victoria S Warbey, Lucy Pike, John Radford, Osama Sabri, Regine Kluge, Sally F Barrington
Μορφή:	Άρθρο
Γλώσσα:	English
Έκδοση:	Public Library of Science (PLoS) 2023-01-01
Σειρά:	PLoS ONE
Διαθέσιμο Online:	https://doi.org/10.1371/journal.pone.0283694

Παρόμοια τεκμήρια

Quantitative assessment of interim PET in Hodgkin lymphoma: An evaluation of the qPET method in adult patients in the RAPID trial.
ανά: Thomas W Georgi, κ.ά.
Έκδοση: (2020-01-01)

Quantitative evaluation of interim positron emission tomography in peripheral T-cell lymphoma
ανά: Lars Kurch, κ.ά.
Έκδοση: (2021-09-01)

Inter-Reader Reliability of Early FDG-PET/CT Response Assessment Using the Deauville Scale after 2 Cycles of Intensive Chemotherapy (OEPA) in Hodgkin's Lymphoma.
ανά: Regine Kluge, κ.ά.
Έκδοση: (2016-01-01)

Interim FDG-PET Scan in Hodgkin's Lymphoma: Hopes and Caveats
ανά: M. André, κ.ά.
Έκδοση: (2011-01-01)

Automatic classification of lymphoma lesions in FDG-PET–Differentiation between tumor and non-tumor uptake
ανά: Thomas W Georgi, κ.ά.
Έκδοση: (2022-01-01)

Automatic classification of lymphoma lesions in FDG-PET-Differentiation between tumor and non-tumor uptake.
ανά: Thomas W Georgi, κ.ά.
Έκδοση: (2022-01-01)

End-of-treatment PET in early-stage Hodgkin lymphoma: valuable in addition to interim PET
ανά: Karan L. Chohan, κ.ά.
Έκδοση: (2022-12-01)

Interim FDG-PET/CT for therapy monitoring and prognostication in Hodgkin’s Lymphoma
ανά: Akram Al-Ibraheem, κ.ά.
Έκδοση: (2022-10-01)

Interim PET for prognosis in adults with Hodgkin lymphoma: A prognostic factor exemplar review
ανά: Skoetz, N, κ.ά.
Έκδοση: (2017)

Interim PET-directed therapy in limited-stage Hodgkin lymphoma initially treated with ABVD
ανά: Diego Villa, κ.ά.
Έκδοση: (2018-12-01)

Prevention of activated brown adipose tissue on 18F-FDG-PET scans of young lymphoma patients: results of an ancillary study within the EuroNet-PHL-C2 trial
ανά: C. Pötzsch, κ.ά.
Έκδοση: (2023-12-01)

Classical Hodgkin Lymphoma: A Joint Clinical and PET Model to Predict Poor Responders at Interim Assessment
ανά: Elizabeth Katherine Anna Triumbari, κ.ά.
Έκδοση: (2022-09-01)

Whole-body [18F]-FDG-PET/MRI for staging of pediatric non-Hodgkin lymphoma: first results from a single-center evaluation
ανά: L. Kurch, κ.ά.
Έκδοση: (2021-07-01)

Interim-treatment quantitative PET parameters predict progression and death among patients with hodgkin's disease
ανά: Tseng Diane, κ.ά.
Έκδοση: (2012-01-01)

Hodgkin lymphoma: hypodense lesions in mediastinal masses
ανά: Adrian Damek, κ.ά.
Έκδοση: (2024-06-01)

Interim PET-results for prognosis in adults with Hodgkin lymphoma: a systematic review and meta-analysis of prognostic factor studies
ανά: Aldin, A, κ.ά.
Έκδοση: (2019)

Interim PET‐results for prognosis in adults with Hodgkin lymphoma: A systematic review and meta‐analysis of prognostic factor studies
ανά: Aldin, A, κ.ά.
Έκδοση: (2020)

P105: Decisional role of interim PET in relapsed/refractory classical Hodgkin Lymphoma treated with four begev cycles
ανά: Chiara Rusconi, κ.ά.
Έκδοση: (2022-10-01)

S225: CIRCULATING TUMOR DNA IS A PROGNOSTIC BIOMARKER AT BASELINE AND IMPROVES THE ACCURACY OF INTERIM PET IN CLASSIC HODGKIN LYMPHOMA
ανά: M. C. Pirosa, κ.ά.
Έκδοση: (2022-06-01)

Does Interim PET Scan After 2 Cycles of ABVD Predict Outcome in Hodgkin Lymphoma? Real-World Evidence
ανά: Arun Seshachalam, κ.ά.
Έκδοση: (2019-12-01)

P033 (0007) SINGLE CENTER ANALYSIS OF NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA: FOCUS ON R-ABVD AND INTERIM PET
Έκδοση: (2018-10-01)

P1070: DECISIONAL ROLE OF INTERIM PET IN RELAPSED/REFRACTORY CLASSICAL HODGKIN LYMPHOMA TREATED WITH BEGEV CHEMOTHERAPY AS FIRST SALVAGE
ανά: Chiara Rusconi, κ.ά.
Έκδοση: (2023-08-01)

FDG-PET as a biomarker for early response in diffuse large B-cell lymphoma as well as in Hodgkin lymphoma? Ready for implementation in clinical practice?
ανά: Josée M. Zijlstra, κ.ά.
Έκδοση: (2016-11-01)

Interim results of a UK NCRI randomised trial comparing involved field radiotherapy with no further treatment after 3 cycles ABVD and a negative PET scan in clinical stages IA/IIA Hodgkin lymphoma
ανά: Radford, J, κ.ά.
Έκδοση: (2007)

Maximum tumor diameter is associated with event-free survival in PET-negative patients with stage I/IIA Hodgkin lymphoma
ανά: Tim M. Illidge, κ.ά.
Έκδοση: (2020-01-01)

P108: Integrating baseline circulating tumor DNA with interim PET improves outcome prediction in relapsed/refractory classical Hodgkin lymphoma
ανά: Eleonora Calabretta, κ.ά.
Έκδοση: (2022-10-01)

P026 (0057) INTERIM- PET RESULTS FOR PROGNOSIS IN ADULTS WITH HODGKIN LYMPHOMA: A PROGNOSTIC FACTOR EXEMPLAR REVIEW (PRELIMINARY RESULTS)
Έκδοση: (2018-10-01)

P004: Advanced stage classical Hodgkin lymphoma (cHL) patients with a positive interim-PET (PET-2) Deauville score (DS) 5 after 2 ABVD cycles: A pooled analysis of individual patient data of three multicenter trials
ανά: Simonetta Viviani, κ.ά.
Έκδοση: (2022-10-01)

Vital Hepatic Lymphoma Residuum or Excessive Immune Response? Challenging Treatment Decisions in a Patient With Systemic Lupus Erythematosus and Liver-Dominant Diffuse Large B-Cell Lymphoma: Case Report
ανά: Lars Kurch, κ.ά.
Έκδοση: (2022-01-01)

The role of FDG-PET in Hodgkin lymphoma
ανά: Edyta Subocz, κ.ά.
Έκδοση: (2017-06-01)

Healthy tissue metabolism assessed by [18F]FDG PET/CT as a marker of prognosis and adverse events in advanced Hodgkin lymphoma patients
ανά: Afnan A. Malaih, κ.ά.
Έκδοση: (2024-06-01)

The importance of harmonizing interim positron emission tomography in non-Hodgkin lymphoma: focus on the Deauville criteria
ανά: Elske Quak, κ.ά.
Έκδοση: (2014-06-01)

The predictive role of interim positron emission tomography for Hodgkin lymphoma treatment outcome is confirmed using the interpretation criteria of the Deauville five-point scale
ανά: Andrea Gallamini, κ.ά.
Έκδοση: (2014-06-01)

The utility of PET/CT with 18F-FDG in the study of Hodgkin's lymphoma and non-Hodgkin's lymphoma
ανά: Marta Milhões, κ.ά.
Έκδοση: (2015-11-01)

Risk and Response Adapted Treatment Guidelines for Managing First Relapsed and Refractory Classical Hodgkin Lymphoma in Children and Young People. Recommendations from the EuroNet Pediatric Hodgkin Lymphoma Group
ανά: Stephen Daw, κ.ά.
Έκδοση: (2020-02-01)

T020: Interim PET-guided treatment of early-stage nodular lymphocyte-predominant Hodgkin lymphoma: a subgroup analysis of the GHSG HD16 and HD17 studies
ανά: Dennis A. Eichenauer, κ.ά.
Έκδοση: (2022-10-01)

Interobserver delineation uncertainty in involved-node radiation therapy (INRT) for early-stage Hodgkin lymphoma: on behalf of the Radiotherapy Committee of the EORTC lymphoma group
ανά: Aznar, M, κ.ά.
Έκδοση: (2017)

MRI versus CT and PET/CT in the Preoperative Assessment of Hodgkin and Non-Hodgkin Lymphomas
ανά: Francesca Maccioni, κ.ά.
Έκδοση: (2021-10-01)

Fluorine-18 fluorodeoxyglucose PET-CT for extranodal staging of non-Hodgkin and Hodgkin lymphoma
ανά: Özgür Ömür, κ.ά.
Έκδοση: (2014-03-01)

Machine Learning to Predict Interim Response in Pediatric Classical Hodgkin Lymphoma Using Affordable Blood Tests
ανά: Jennifer A. Geel, κ.ά.
Έκδοση: (2024-10-01)